
Wegovy (Injection & Pill)
Wegovy (semaglutide) is an FDA-approved GLP-1 medication for long-term weight loss. We prescribe all three forms: the weekly injection, the higher-dose Wegovy HD, and the once-daily pill.
Qsymia is an FDA-approved combination of phentermine and topiramate that reduces hunger and supports metabolism. Alabama law requires a monthly in-person visit for each prescription.
Qsymia combines two medications:
Together, they:
Patients using Qsymia under medical supervision may experience:
You may qualify for Qsymia if you:
Because Qsymia contains phentermine, it is classified as a controlled substance. Alabama law requires monthly in-person visits and limits prescriptions to a maximum of 35 days at a time.
When you begin treatment with Qsymia at PrecisionMD, you’ll receive:
Suppress appetite, support metabolism, and achieve real results.
Qsymia care is provided in person only at our Decatur and Madison clinics, with monthly visits required for refills. Patients from Huntsville, Athens, Cullman, Hartselle, Hazel Green, Harvest, and New Market also come to us for physician-supervised weight loss care.

Physician-led care
Every plan at PrecisionMD follows the protocols of Dr. Traci McCormick, MD, triple board-certified in Obesity Medicine, Lifestyle Medicine and Radiation Oncology.
Where to get it
This treatment needs an in-person visit. Choose the clinic closest to you.
Questions
Still unsure? Call or text (256) 286-1888.
Both are oral weight loss medications, but they work in different ways. Contrave primarily targets cravings and emotional eating, while Qsymia combines appetite suppression with metabolic support.
No strict diet is required. Qsymia helps reduce appetite and improve metabolism, which makes healthy eating easier to maintain. Long-term results come from pairing the medication with balanced nutrition and sustainable lifestyle changes, not rigid dieting.
Some patients notice reduced appetite within the first few weeks, while weight loss typically builds gradually with consistent use and lifestyle support. Your provider will monitor progress and make adjustments as needed.
Like other weight loss medications, Qsymia works best as part of a long-term plan. If you stop taking it without maintaining healthy habits, weight regain is possible. Our providers help you build lasting changes so you have the best chance of keeping the weight off.
No. Because Qsymia contains phentermine, it requires monthly in-person visits in Alabama. Telehealth check-ins may be used for additional support but do not replace the in-person requirement.
At PrecisionMD, Qsymia is available for about $100 per month through our clinic. We can also prescribe the generic components (phentermine and topiramate) separately, which are often available at local pharmacies for much less, giving you flexibility based on cost and insurance coverage.
On average, patients taking Qsymia lose about 7–10% of their starting body weight over time when combined with healthy lifestyle changes. Some patients may lose more and others less, depending on factors like metabolism, medical conditions, and consistency with nutrition and activity. The important thing is that Qsymia works best as part of a long-term, sustainable plan, not as a quick fix.
Because Qsymia combines phentermine with topiramate, side effects may include dry mouth, constipation, insomnia, tingling in the hands or feet, or changes in taste. These are usually mild and improve as your body adjusts. Serious side effects are uncommon but can include mood changes, memory issues, or eye problems. At PrecisionMD, we require monthly in-person visits to monitor your safety and adjust treatment if needed.
More in Weight Loss

Wegovy (semaglutide) is an FDA-approved GLP-1 medication for long-term weight loss. We prescribe all three forms: the weekly injection, the higher-dose Wegovy HD, and the once-daily pill.

Zepbound (tirzepatide) is an FDA-approved weekly injection that acts on two hormone pathways, GLP-1 and GIP, to reduce appetite and support your metabolism.

Foundayo (orforglipron), approved by the FDA on April 1, 2026, is the first oral GLP-1 weight loss pill you can take at any time of day, with or without food, so the medication fits your routine instead of the other way around.

Your first visit
Every new patient begins with a consultation: your history, your goals, and a clear plan. In person in Decatur or Madison, or by telehealth anywhere in Alabama.
Decatur · Madison · Telehealth across Alabama